Rivas-Espinosa J, Trigos-Landa A, Bocanegra-García V, Acosta-González RI, Bocanegra-Alonso A, Rivera-Sánchez G

Language: English
References: 21
Page: 140-145
PDF size: 115.47 Kb.

ABSTRACT

Hyperprolactinemia leads to several diagnoses, however, the immunoassay used for the prolactin determination and the presence of macroprolactin, could induce a misdiagnosis. The aim of this study was to evaluate the usefulness of separation and detection of macroprolactin by precipitation with polyethylene glycol, using two commercial immunoassays, Axsym Abbott and Advia Centaur Bayer in patients with established diagnosis of hyperprolactinemia. One hundred and seventeen samples were tested. Samples were obtained from female patients aged between 22 to 59 years old. We determined total prolactin (PRL), macroprolactin and free prolactin. In 30 of these samples hyperprolactinemia was detected. PRL recovering percentages of supernatant fraction were from 6.5% to 78.5% and from 26.2% to 75.4% when we compared Advia to Axsym systems initial values, respectively. Based on the PRL recovering percentage, 7 samples with significant macro-PRL presence were observed. The macroprolactin prevalence in these 30 samples, after PEG precipitation, was of 23% and 10% in the Axsym and Advia system respectively. Based upon these findings, we establish that references values need to be determined for both instruments, having applied the polyethylene glycol precipitation for the prolactine determination.

REFERENCES

1. Gibney J, Smith PT, Mackenna TJ. Clinical relevance of macroprolactin. Clin Endocrinol 2005; 62: 633-643.

2. Biller BM. Hyperprolactinaemia. Int J Fertil Womens Med 1999; 44: 74-77.

3. Zacur H. Indications for surgery in the treatment of hyperprolactinaemia. J Reprod Med 1999; 44: 1127-1131.

4. Hattori N. The Frequency of macroprolactinaemia in pregnant woman and the heterogeneity of its etiologies. J Clin Endocrinol Metab 1996; 81: 586-590.

5. Diver MJ, Ewins DL, Worth R, Bowles S, Ahlquist J, Fahie-Wilson MN. An unusual form of big big (macro) prolactin in a pregnant patient. Clin Chem 2001; 47: 346-348.

6. John R, McDowell IFW, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clin Chem 2000; 46: 884-885.

7. Olukaga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol 1999; 51: 119-126.

8. Leslie H, Courtney CH, Bell PM, Hadden DR, McCane DR, Elis PK. Laboratory and clinical experience in 55 Patients with macroprolactinaemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 2001; 86: 2743-2746.

9. Fahie-Wilson MN, Brunsden P, Surrey J, Everitt A. Macroprolactin and the Roche elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin Chem 2000; 46: 1993-1995.

10. Smith PT, Sulliman MA, Fahie-Wilson NM, McKenna TJ. Gross variability in the detection of prolactin in sera containing big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 2002; 87: 5410-5415.

11. Schneider W, Marcovitz S, Al-Shammari S, Yago S, Chevalier S. Reactivity of macroprolactin in common automated immunoassays. Ann Clin Biochem 2001; 34: 469-473.

12. Pascoe LD, Duran RG, Contreras HI, Manuel AL, Blanco FF, Leaños MA. Frequency of macroprolactinaemia due to antibodies against prolactin in pregnant woman. J Clin Endocrinol Metab 2001; 86: 924-929.

13. Gilson G, Schmit P, Thix J, Hoffman J, Humbel R. Prolactin results for samples containing macroprolactin are method and sample dependant. Clin Chem 2001; 47: 331-333.

14. Schlechte JA. The macroprolactin problem. J Clin Endocrinol Metab 2002; 87: 5408-5409.

15. Guitelman MA. Macroprolactinaemia (macro-PRL) a través del método de precipitación con polietileglicol (PEG). Rev End Gin Rep 2002; 9: 7-19.

16. Fahie-Wilson MN. Detection of macroprolactin causing hyperprolactinaemia in commercial assays for prolactin. Clin Chem 2000; 46: 2022-2023.

17. Vallette KS, Morange RI, Selim A, Gunz G, Mornage S, Enjalbert A. Macroprolactinaemia revisited: a study on 106 patients. J Clin Endocrinol Metab 2002; 87: 581-588.

18. Sapin R, Simon CH. False hyperprolactinaemia corrected by the use of heterofilic antibody-blocking agent. Clin Chem 2001; 47: 2184-2185.

19. García ML, Diez HA, Ciriza C, Delgado GM, Orejas GA, Fernández EA. Macroprolactin as etiology of hyperproactinemia. Method for detection and clinical characterization of the entity in 39 patients. Rev Clin Esp 2003; 203: 459-464.

20. Fahie-Wilson M. In hyperprolactinaemia testing for macroprolactin is essential. Clin Chem 2003; 49: 1434-1436.

21. Serri O, Chik CL, Ur E, Ezzat S. Diagnosis and management of hyperprolactinaemia. Can Med Assoc J 2003; 169: 575-581.